Archived explainer. For the current picture see today's BSX page.
Why Is BOSTON SCIENTIFIC CO (BSX) Stock Moving Today?
By the Top Tier Newswire AI Desk · August 31, 2026 at 3:26 AM ET · reviewed against 1 wire stories
BOSTON SCIENTIFIC CO (BSX) is drawing unusual attention today. Our newswire has captured 1 story on BSX across 1 source in the last 36 hours, with AI sentiment reading mixed (avg 53/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Boston Scientific Co (BSX) stock is moving lower today, down 9.9% in the last eight sessions as the share price declined from $52.01 to $46.84. The drop is attributed to a cybersecurity incident that disrupted the company’s global operations, including order processing and shipping. The incident has raised concerns about operational resilience and potential impacts on revenue, particularly in a sector where consistent service delivery is critical.
What Happened
Boston Scientific disclosed a cybersecurity threat that has caused a global disruption to its operations. The company is currently investigating the incident, which has affected key functions such as order fulfillment and shipping. This news comes amid a broader market decline, as the Nasdaq 100 fell on rising inflation concerns and renewed rate-hike expectations. The healthcare sector, already under pressure, saw Boston Scientific and other names like Veeva Systems and Lilly highlighted in recent market updates. Boston Scientific’s recall-related issues further contributed to the negative sentiment around the stock.
What The Data Shows
The stock has a beta of 0.57, indicating it is less volatile than the broader market, but the recent cybersecurity incident has pushed sentiment lower. The 30-day average sentiment score is 44 out of 100, dropping to 39 in the last seven days. Insider activity has been largely positive, with five insider buys totaling $9.5 million in the last 90 days, most recently on August 26. Congressional activity includes recent buys and sells by Rep. Ro Khanna, with the most recent purchase on July 20. Despite these, the stock’s price trend over the past eight sessions has been sharply downward.
What To Watch
Boston Scientific has not scheduled any earnings reports in the immediate future. Investors should monitor the breadth of coverage and the outcome of the ongoing cybersecurity investigation, as well as any follow-up from analysts or regulatory bodies.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
BSX · Aug 31 session (5-min) · +3.12% vs prior close · updated 8:56 PM ETAI sentiment, last 36h · averaged over 1 story · 53/100 neutral
The headlines behind the move
Story flow · 1 story on the wire, last 36h · hover or tap a dot for the headline
13d agoSeeking AlphaNEUTRAL 53General
Notable healthcare headlines for the week: Veeva Systems, Boston Scientific in focus
Weekly healthcare stock market update: XLV dips as Veeva surges, BSX recall hits, Lilly wins FDA label, and Moderna notes.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →